NCT05812677 2023-04-14
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
Shanghai Yunying Medical Technology
Shanghai OriginCell Therapeutics Co., Ltd.